
![]() |
![]() |
|||||||||
| Privacy Policy | ||||||||||
|
CardioVascular BioTherapeutics, Inc. is committed to protecting the privacy of our consumers, shareholders and users of our Website. Any user information gathered on this Website may be used for aggregate research, future improvement of the Website and to better meet your needs. CardioVascular BioTherapeutics, Inc. will not disclose personal identifiable information that you provide on this Website to any third parties other than to a CardioVascular BioTherapeutics, Inc. agent, except (1) when we have your permission or (2) to comply with valid legal requirements such as by law, regulation, warrant, subpoena or court order.
Use of
this site constitutes agreement to our Terms and Conditions | ||||||||||
2/24/2009
CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
1/8/2009
CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial
12/11/2008
CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease